James C. Vickers
Affiliations: | University of Tasmania, Sandy Bay, Tasmania, Australia |
Area:
alzheimer's disease, cytoskeleton, traumatic brain injuryGoogle:
"James Vickers"Mean distance: 14.34 (cluster 19) | S | N | B | C | P |
Cross-listing: Alzheimer's Tree
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Brown DT, Vickers JC, Stuart KE, et al. (2020) The Val66Met Polymorphism Modulates Resilience of Neurological Functioning to Brain Ageing and Dementia: A Narrative Review. Brain Sciences. 10 |
Collins JM, Woodhouse A, Bye N, et al. (2020) Pathological links between traumatic brain injury and dementia: Australian pre-clinical research. Journal of Neurotrauma |
Tian N, Hanson KA, Canty AJ, et al. (2019) Microtubule-dependent processes precede pathological calcium influx in excitotoxin-induced axon degeneration. Journal of Neurochemistry |
Konttinen H, Cabral-da-Silva MEC, Ohtonen S, et al. (2019) PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia. Stem Cell Reports |
Stuart KE, King AE, King NE, et al. (2019) Late-Life Environmental Enrichment Preserves Short-Term Memory and May Attenuate Microglia in Male APP/PS1 Mice. Neuroscience |
Collins JM, King AE, Woodhouse A, et al. (2019) Age moderates the effects of traumatic brain injury on beta-amyloid plaque load in APP/PS1 mice. Journal of Neurotrauma |
Hanson K, Tian N, Vickers JC, et al. (2018) The HDAC6 Inhibitor Trichostatin A Acetylates Microtubules and Protects Axons From Excitotoxin-Induced Degeneration in a Compartmented Culture Model. Frontiers in Neuroscience. 12: 872 |
Woodhouse A, Fernandez-Martos CM, Atkinson RAK, et al. (2018) Repeat propofol anesthesia does not exacerbate plaque deposition or synapse loss in APP/PS1 Alzheimer's disease mice. Bmc Anesthesiology. 18: 47 |
King A, Brain A, Hanson K, et al. (2018) Disruption of leptin signalling in a mouse model of Alzheimer's disease. Metabolic Brain Disease |
Fernandez-Martos CM, Atkinson RAK, Chuah MI, et al. (2017) Combination treatment with leptin and pioglitazone in a mouse model of Alzheimer's disease. Alzheimer's & Dementia (New York, N. Y.). 3: 92-106 |